Vascular and Endovascular Review (discontinued)
SJR0.321
AE
AEJournal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2024 | — | — | 0.321 | Q3 | 47.8% | |
| 2023 | — | — | 0.245 | Q3 | 42.2% | |
| 2022 | — | — | 0.247 | Q3 | 44.6% | |
| 2021 | — | — | — | 0.0% | ||
| 2020 | — | — | — | 0.0% | ||
| 2019 | — | — | — | 0.0% | ||
| 2018 | — | — | — | 0.0% | ||
Impact history
Annual SJR and Impact Factor trend.
SJR
Journal record
eISSN
2516-3302
ISSN
2516-3299
country
AEcoverage
2018-2024